Cy5.5 Antibody
Cy5.5 Antibody
Anti-human CD5 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC00480-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD5 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD45 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC00555-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD45 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD2 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC00570-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD2 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD16 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC01408-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD16 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD22 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC01572-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD22 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD8 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC02236-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD8 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD13 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC02591-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD13 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD3 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC02675-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 160 EUR |
|
Description: Mouse Monoclonal human CD3 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD10 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC04065-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 166 EUR |
|
Description: Mouse Monoclonal human CD10 Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human HLA-DR Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC00568-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human HLA-DR Antibody PerCP-Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Anti-human CD20 PerCP Monoclonal Antibody PerCP Cy5.5 Conjugated, Flow Validated |
|||
| FC03780-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Monoclonal human CD20 PerCP Antibody PerCP Cy5.5 Conjugated, Flow Validated. Validated in Flow Cytometry and tested in Human. |
|||
Mouse anti-human CD7 Monoclonal Antibody PerCP-Cy5.5 Conjugated, Flow Validated |
|||
| FC01974-1-PerCP-Cy5.5 | BosterBio | 25 Tests, 100 Tests, 200 Tests | 200 EUR |
|
Description: Mouse Mouse Monoclonal Anti-human CD7 PerCP-Cy5.5 Conjugated, designed for Flow Cytometry and validated by Flow Cytometry using Human cells. |
|||
CY5.5-COOH |
|||
| abx187851-1g | Abbexa | 1 g | 1831 EUR |
CD45.1 Antibody (PerCP-Cy5.5) |
|||
| 20-abx200805 | Abbexa |
|
|
CD45.2 Antibody (PerCP-Cy5.5) |
|||
| 20-abx200813 | Abbexa |
|
|
CD45RB Antibody (PerCP-Cy5.5) |
|||
| 20-abx200831 | Abbexa |
|
|
CD90.2 Antibody (PerCP-Cy5.5) |
|||
| 20-abx200919 | Abbexa |
|
|
H2Db Antibody (PerCP-Cy5.5) |
|||
| 20-abx200944 | Abbexa |
|
|
H2Dd Antibody (PerCP-Cy5.5) |
|||
| 20-abx200952 | Abbexa |
|
|
Ly6G Antibody (PerCP-Cy5.5) |
|||
| 20-abx201008 | Abbexa |
|
|
Ly6C Antibody (PerCP-Cy5.5) |
|||
| 20-abx201023 | Abbexa |
|
|
CD16 antibody (PE-CY5.5) |
|||
| 61R-CD16gMSPEC5 | Fitzgerald | 100 ug | 349 EUR |
|
Description: Rat monoclonal CD16 antibody (PE-CY5.5) |
|||
CD19 antibody (PE-CY5.5) |
|||
| 61R-CD19aMSPEC5 | Fitzgerald | 100 ug | 349 EUR |
|
Description: Rat monoclonal CD19 antibody (PE-CY5.5) |
|||
CD19 antibody (PE-CY5.5) |
|||
| 61R-CD19cHUPEC5 | Fitzgerald | 100 tests | 381 EUR |
|
Description: Mouse monoclonal CD19 antibody (PE-CY5.5) |
|||
CD19 antibody (PE-CY5.5) |
|||
| 61R-CD19dMSPEC5 | Fitzgerald | 100 ug | 403 EUR |
|
Description: Mouse monoclonal CD19 antibody (PE-CY5.5) |
|||
CD3 antibody (PE-CY5.5) |
|||
| 61R-CD3gHUPEC5 | Fitzgerald | 100 tests | 381 EUR |
|
Description: Mouse monoclonal CD3 antibody (PE-CY5.5) |
|||
CD45.1 antibody (PE-CY5.5) |
|||
| 61R-CD45gMSPEC5 | Fitzgerald | 100 ug | 457 EUR |
|
Description: Mouse monoclonal CD45.1 antibody (PE-CY5.5) |
|||
CD45.2 antibody (PE-CY5.5) |
|||
| 61R-CD45hMSPEC5 | Fitzgerald | 100 ug | 457 EUR |
|
Description: Mouse monoclonal CD45.2 antibody (PE-CY5.5) |
|||
CD45R antibody (PE-CY5.5) |
|||
| 61R-CD45RcMSPE5 | Fitzgerald | 100 ug | 403 EUR |
|
Description: Rat monoclonal CD45R antibody (PE-CY5.5) |
|||
CD4 antibody (Allophycocyanin-CY5.5) |
|||
| 61R-CD4eMSAPC5 | Fitzgerald | 100 ug | 316 EUR |
|
Description: Rat monoclonal CD4 antibody (Allophycocyanin-CY5.5) |
|||
CD4 antibody (PE-CY5.5) |
|||
| 61R-CD4eMSPEC5 | Fitzgerald | 100 ug | 381 EUR |
|
Description: Rat monoclonal CD4 antibody (PE-CY5.5) |
|||
CD4 antibody (PE-CY5.5) |
|||
| 61R-CD4kHUPEC5 | Fitzgerald | 100 tests | 381 EUR |
|
Description: Mouse monoclonal CD4 antibody (PE-CY5.5) |
|||
CD56 antibody (PE-CY5.5) |
|||
| 61R-CD56bHUPEC5 | Fitzgerald | 100 tests | 435 EUR |
|
Description: Mouse monoclonal CD56 antibody (PE-CY5.5) |
|||
CD8a antibody (PE-CY5.5) |
|||
| 61R-CD8abMSPEC5 | Fitzgerald | 100 ug | 349 EUR |
|
Description: Rat monoclonal CD8a antibody (PE-CY5.5) |
|||
Sialoadhesin (CD169) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200718 | Abbexa |
|
|
CD16+CD32 Antibody (PerCP-Cy5.5) |
|||
| 20-abx200726 | Abbexa |
|
|
B220 / CD45R Antibody (PerCP-Cy5.5) |
|||
| 20-abx200837 | Abbexa |
|
|
NK-1.1 Antibody (PerCP-Cy5.5) |
|||
| 20-abx201031 | Abbexa |
|
|
TCR beta Antibody (PerCP-Cy5.5) |
|||
| 20-abx201039 | Abbexa |
|
|
DSPE-PEG-CY5.5 |
|||
| abx085192-10kDa100mg | Abbexa | 10 kDa; 100 mg | 1107 EUR |
DSPE-PEG-CY5.5 |
|||
| abx085192-2kDa100mg | Abbexa | 2 kDa; 100 mg | 1107 EUR |
DSPE-PEG-CY5.5 |
|||
| abx085192-5kDa100mg | Abbexa | 5 kDa; 100 mg | 1107 EUR |
CY5.5-PEG-SH |
|||
| abx085229-10kDa50mg | Abbexa | 10 kDa; 50 mg | 801 EUR |
CY5.5-PEG-SH |
|||
| abx085229-1kDa50mg | Abbexa | 1 kDa; 50 mg | 801 EUR |
CY5.5-PEG-SH |
|||
| abx085229-2kDa50mg | Abbexa | 2 kDa; 50 mg | 801 EUR |
CY5.5-PEG-SH |
|||
| abx085229-34kDa50mg | Abbexa | 3.4 kDa; 50 mg | 801 EUR |
CY5.5-PEG-SH |
|||
| abx085229-5kDa50mg | Abbexa | 5 kDa; 50 mg | 801 EUR |
CY5.5-PEG-FA |
|||
| abx085302-10kDa100mg | Abbexa | 10 kDa; 100 mg | 1107 EUR |
CY5.5-PEG-FA |
|||
| abx085302-2kDa100mg | Abbexa | 2 kDa; 100 mg | 1107 EUR |
CY5.5-PEG-FA |
|||
| abx085302-34kDa100mg | Abbexa | 3.4 kDa; 100 mg | 1107 EUR |
CY5.5-PEG-FA |
|||
| abx085302-5kDa100mg | Abbexa | 5 kDa; 100 mg | 1107 EUR |
CY5.5-PEG-NH2 |
|||
| abx085367-10kDa50mg | Abbexa | 10 kDa; 50 mg | 546 EUR |
CY5.5-PEG-NH2 |
|||
| abx085367-20kDa50mg | Abbexa | 20 kDa; 50 mg | 546 EUR |
CY5.5-PEG-NH2 |
|||
| abx085367-2kDa50mg | Abbexa | 2 kDa; 50 mg | 523 EUR |
CY5.5-PEG-NH2 |
|||
| abx085367-5kDa50mg | Abbexa | 5 kDa; 50 mg | 539 EUR |
CY5.5-PEG-N3 |
|||
| abx085404-2kDa50mg | Abbexa | 2 kDa; 50 mg | 523 EUR |
CY5.5-PEG-NH2,2K |
|||
| FL079005-10K-50mg | Biochempeg | 50mg | 470 EUR |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CY5.5-PEG-NH2,2K |
|||
| FL079005-20K-50mg | Biochempeg | 50mg | 470 EUR |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CY5.5-PEG-NH2,2K |
|||
| FL079005-2K-50mg | Biochempeg | 50mg | 470 EUR |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CY5.5-PEG-NH2,2K |
|||
| FL079005-3.4K-50mg | Biochempeg | 50mg | 470 EUR |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CY5.5-PEG-NH2,2K |
|||
| FL079005-5K-50mg | Biochempeg | 50mg | 470 EUR |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
CY5.5-PEG-N3,2K |
|||
| FL079006-2K-50mg | Biochempeg | 50mg | 470 EUR |
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
APC-Cy5.5 Tandem |
|||
| 2622 | AAT Bioquest | 1 mg | 219 EUR |
Streptavidin-Cy5.5 conjugate |
|||
| SV-C5-100 | Alpha Diagnostics | 100 tests | 202 EUR |
CD3 Epsilon (CD3E) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200789 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200797 | Abbexa |
|
|
IL12 / IL23 p40 Antibody (PerCP-Cy5.5) |
|||
| 20-abx200960 | Abbexa |
|
|
Interleukin 2 (IL2) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200968 | Abbexa |
|
|
Interleukin 4 (IL4) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200976 | Abbexa |
|
|
Interferon Gamma (IFNG) Antibody (PerCP-Cy5.5) |
|||
| 20-abx200984 | Abbexa |
|
|